Friday Dec 5, 2025
NEWSLETTER
www.israelhayom.com
  • Home
  • News
    • Israel
    • Israel at War
    • Middle East
    • United States
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
  • In Memoriam
www.israelhayom.com
  • Home
  • News
    • Israel
    • Israel at War
    • Middle East
    • United States
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
  • In Memoriam
www.israelhayom.com
Home Health & Wellness

Israel bans Juul e-cigarettes for 'grave' public ‎health risk

The Juul e-cigarette contains 59 milligrams of nicotine per milliliter of ‎liquid, much higher than the 6-30 milligrams per milliliter in other e-cigarettes.‎

by  Maytal Yasur Beit-Or , Reuters and Israel Hayom Staff
Published on  08-22-2018 00:00
Last modified: 10-23-2019 16:22
Share on FacebookShare on Twitter

Israel on Tuesday outlawed the import and sale of electronic cigarettes made by Silicon Valley startup Juul Labs, ‎citing public health concerns over their nicotine ‎content.‎

A statement by Israel's Health Ministry said the ‎Juul e-cigarette, which entered the Israeli market in May, contains more than the European Union limit of 20 milligrams of nicotine ‎per ‎milliliter and poses "a grave risk to public ‎health."‎

The Juul e-cigarette contains 59 milligrams of nicotine per milliliter of ‎liquid, much higher than the 6-30 milligrams per milliliter in other e-cigarettes.‎

While Israel does not regulate the amount of nicotine in e-cigarettes, the ministry said its ban is consistent with similar ‎restrictions in ‎Europe.

The ban, which goes into effect on Sept.3, was ‎‎signed by Deputy Health Minister Yakov Litzman and ‎Prime Minister Benjamin Netanyahu, who holds the ‎health portfolio.‎

Since launching in 2015, Juul's flash drive-sized ‎vaping device and its flavor pods have transformed ‎the market in the United States, where it now ‎accounts for nearly 70% percent of tracked e-cigarette sales.‎

The company is valued at $15 billion.‎

In a statement Tuesday, Juul Labs said it was ‎‎"incredibly disappointed" with what it called a ‎‎"misguided" decision by the Israeli government.‎

The San Francisco-based company said it plans to ‎‎appeal the ban before Israel's High Court of ‎‎Justice, citing "selective enforcement."

The company ‎‎maintains that its device provides smokers with "a true ‎‎alternative to combustible cigarettes."‎

The company criticized the decision as a "dangerous ‎move by the Health Ministry against the smoking ‎public."

"Every Israeli has to think – why ‎does the Health Ministry allow for the sale of ‎cancerous cigarettes and tobacco products but is ‎preventing the sale of an advanced product that has ‎been proved to be a far less harmful alternative to ‎tobacco,"‎ the company said.

A previous attempt to ban the sale of e-cigarettes in Israel was struck down by the High Court.

Juul says it targets adult smokers, but it has faced ‎scrutiny over the popularity of its products with ‎teenagers.‎

In April, the U.S. Food and Drug Administration ‎launched a crackdown on the sale to minors of e-cigarettes and ‎tobacco products, particularly those ‎developed by Juul Labs.‎

Tags: FDAhealth risksmoking

Related Posts

Amazon's new product: A doctor's appointmentREUTERS/Dado Ruvic; Stockbyte/Getty Images;

Amazon's new product: A doctor's appointment

by Erez Linn

Amazon launches pay-per-visit pediatric telehealth service eliminating insurance barriers for families seeking immediate medical care for children's common conditions, with...

COVID is back – with brain fogGetty Images/iStockphoto/SB Arts Media

COVID is back – with brain fog

by Erez Linn

Stratus follows the Nimbus strain, which demonstrates high infectiousness and "razor blade" sore throat symptoms.

Researchers discover Israeli coronavirus variant, but risk lowGetty Images / fotomay

Doctors shocked after coronavirus infects patient for 2 years

by Erez Linn

This extended infection differs significantly from long COVID cases: Instead of post-viral symptoms, this patient continued experiencing the active infectious...

Menu

Analysis 

Archaeology

Blogpost

Business & Finance

Culture

Exclusive

Explainer

Environment

 

Features

Health

In Brief

Jewish World

Judea and Samaria

Lifestyle

Cyber & Internet

Sports

 

Diplomacy 

Iran & The Gulf

Gaza Strip

Politics

Shopping

Terms of use

Privacy Policy

Submissions

Contact Us

About Us

The first issue of Israel Hayom appeared on July 30, 2007. Israel Hayom was founded on the belief that the Israeli public deserves better, more balanced and more accurate journalism. Journalism that speaks, not shouts. Journalism of a different kind. And free of charge.

All rights reserved to Israel Hayom

Hosted by sPD.co.il

  • Home
  • News
    • Israel at War
    • Israel
    • United States
    • Middle East
    • Sports
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
    • Environment & Wildlife
    • Health & Wellness
  • In Memoriam
  • Subscribe to Newsletter
  • Submit your opinion
  • Terms and conditions

All rights reserved to Israel Hayom

Hosted by sPD.co.il

Newsletter

[contact-form-7 id=”508379″ html_id=”isrh_form_Newsletter_en” title=”newsletter_subscribe”]

  • Home
  • News
    • Israel at War
    • Israel
    • United States
    • Middle East
    • Sports
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
    • Environment & Wildlife
    • Health & Wellness
  • In Memoriam
  • Subscribe to Newsletter
  • Submit your opinion
  • Terms and conditions

All rights reserved to Israel Hayom

Hosted by sPD.co.il